Systemic Factors Related to Intraocular Levels of Interleukin-6 and Vascular Endothelial Growth Factor in Diabetic Retinopathy

Journal of Ophthalmology - Egypt
doi 10.1155/2019/4831967
Full Text
Abstract

Available in full text

Categories
Ophthalmology
Date
Authors
Publisher

Hindawi Limited

Related search

Intraocular and Systemic Levels of Vascular Endothelial Growth Factor in Advanced Cases of Retinopathy of Prematurity

Clinical Ophthalmology
Ophthalmology
2010English

Anti-Vascular Endothelial Growth Factor for Proliferative Diabetic Retinopathy

2010English

Upregulated Expression of Vascular Endothelial Growth Factor in Proliferative Diabetic Retinopathy.

British Journal of Ophthalmology
Molecular NeuroscienceOphthalmologySensory SystemsCellular
1996English

Aqueous Interleukin-6 Levels Are Superior to Vascular Endothelial Growth Factor in Predicting Therapeutic Response to Bevacizumab in Age-Related Macular Degeneration

Journal of Ophthalmology
Ophthalmology
2014English

Vascular Endothelial Growth Factor Inhibition for Proliferative Diabetic Retinopathy: Et Tu, Brute?

Acta Ophthalmologica
MedicineOphthalmology
2017English

Vascular Endothelial Growth Factor +405g/C Polymorphism as a Predictor of Diabetic Retinopathy

Bulletin of the National Research Centre
2020English

Serum Vascular Endothelial Growth Factor Load and Interleukin-6 in Cancer Patients – Reply

British Journal of Cancer
Cancer ResearchOncology
2000English

Is Blockade of Vascular Endothelial Growth Factor Beneficial for All Types of Diabetic Retinopathy?

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
2008English

IL-4, IL-6, IL-10, IL-17A and Vascular Endothelial Growth Factor in the Vitreous of Patients With Proliferative Diabetic Retinopathy

Advances in Bioscience and Biotechnology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy